Adjunct Professor of Bioengineering and Experimental Sciences at UCSF
I’m investing in Tactogen because they have made great progress in designing and developing novel entactogens, and are simultaneously applying a novel business/funding structure. Tactogen has a deep appreciation for the role of community and connection in healing and wellness. If successful, Tactogen could support healing in many people and improve health equity writ large. I am excited about this journey, and hope that other companies in our young sector will take note.